AIM ImmunoTech Inc (AIM)
0.2611
0.00 (0.00%)
USD |
NYAM |
Nov 01, 16:00
0.25
-0.01
(-4.25%)
After-Hours: 20:00
AIM ImmunoTech Shareholders Equity (Quarterly): 6.102M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 6.102M |
March 31, 2024 | 4.826M |
December 31, 2023 | 10.23M |
September 30, 2023 | 22.60M |
June 30, 2023 | 30.14M |
March 31, 2023 | 34.99M |
December 31, 2022 | 38.47M |
September 30, 2022 | 42.70M |
June 30, 2022 | 48.78M |
March 31, 2022 | 53.30M |
December 31, 2021 | 56.88M |
September 30, 2021 | 62.05M |
June 30, 2021 | 65.53M |
March 31, 2021 | 70.97M |
December 31, 2020 | 61.29M |
September 30, 2020 | 61.11M |
June 30, 2020 | 46.99M |
March 31, 2020 | 35.11M |
December 31, 2019 | 13.44M |
September 30, 2019 | 13.84M |
June 30, 2019 | 6.548M |
March 31, 2019 | 3.93M |
December 31, 2018 | 5.174M |
September 30, 2018 | 6.439M |
June 30, 2018 | 9.096M |
Date | Value |
---|---|
March 31, 2018 | 10.20M |
December 31, 2017 | 8.703M |
September 30, 2017 | 10.04M |
June 30, 2017 | 10.33M |
March 31, 2017 | 12.95M |
December 31, 2016 | 15.50M |
September 30, 2016 | 16.63M |
June 30, 2016 | 17.49M |
March 31, 2016 | 18.41M |
December 31, 2015 | 20.37M |
September 30, 2015 | 23.17M |
June 30, 2015 | 26.76M |
March 31, 2015 | 26.97M |
December 31, 2014 | 25.00M |
September 30, 2014 | 26.36M |
June 30, 2014 | 29.37M |
March 31, 2014 | 31.99M |
December 31, 2013 | 29.30M |
September 30, 2013 | 32.15M |
June 30, 2013 | 36.14M |
March 31, 2013 | 41.38M |
December 31, 2012 | 44.70M |
September 30, 2012 | 36.61M |
June 30, 2012 | 33.54M |
March 31, 2012 | 36.13M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
4.826M
Minimum
Mar 2024
70.97M
Maximum
Mar 2021
40.29M
Average
42.70M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
Perspective Therapeutics Inc | 341.00M |
Protalix BioTherapeutics Inc | 28.58M |
Electromed Inc | 44.54M |
Xtant Medical Holdings Inc | 45.00M |
Armata Pharmaceuticals Inc | -46.10M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 15.72M |
Total Liabilities (Quarterly) | 9.613M |
Debt to Equity Ratio | 0.4322 |
Current Ratio | 1.172 |
Net Debt Paydown Yield | -2.48% |